[Co-occurrence of multilocular prostatic cystadenoma and incidental low-risk adenocarcinoma in a young male patient].

IF 0.9 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Orvosi hetilap Pub Date : 2024-12-29 DOI:10.1556/650.2024.33198
Péter Czétány, Dániel Bányai, Levente Kuthi, Dávid Semjén
{"title":"[Co-occurrence of multilocular prostatic cystadenoma and incidental low-risk adenocarcinoma in a young male patient].","authors":"Péter Czétány, Dániel Bányai, Levente Kuthi, Dávid Semjén","doi":"10.1556/650.2024.33198","DOIUrl":null,"url":null,"abstract":"<p><p>In the background of the urinary symptoms of a young, 31-year-old male patient pelvic MRI revealed a multilocular cystic tumor measuring 7.6 cm in diameter on the right side of the pelvis. Given his symptoms and the possibility of malignancy, a transperitoneal laparoscopic resection was performed. Histological examination confirmed the diagnosis of prostatic cystadenoma, and an incidental finding of Gleason-grade 3 + 3 adenocarcinoma was also noted in a small focus. Postoperatively, the patient became completely asymptomatic, with neither urinary symptoms nor erectile/ejaculatory dysfunction. A follow-up MRI performed 3 months later showed no recurrence, and PSA levels showed significant regression. The patient continues to be monitored closely. The prostatic cystadenoma is an exceedingly rare benign tumor, with fewer than 50 cases reported to date. Preoperative diagnosis is challenging due to the nonspecific nature of its compressive urogenital and gastrointestinal symptoms. Basic investigations, such as physical examination, ultrasound and PSA testing, are often uninformative. More detailed diagnostic information can be obtained through higher-order imaging studies (CT, pelvic MRI) or cytological/histological sampling via fine needle or core biopsy. The treatment of prostatic cystadenoma is primarily surgical, involving resection or excision through various approaches (transurethral, laparoscopic, robotic, or open surgery). Complete removal of the tumor is crucial, as incomplete resection is associated with high rate of recurrence. Although prostatic cystadenomas typically exhibit indolent behavior, a case of concurrent high-grade prostatic intraepithelial neoplasia and a further description of conventional adenocarcinoma have been already published. This case is noteworthy as it represents the second documented co-occurrence of prostatic cystadenoma and adenocarcinoma (collision tumor), according to the current literature. Orv Hetil. 2024; 165(52): 2065–2071.</p>","PeriodicalId":19911,"journal":{"name":"Orvosi hetilap","volume":"165 52","pages":"2065-2071"},"PeriodicalIF":0.9000,"publicationDate":"2024-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orvosi hetilap","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1556/650.2024.33198","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

In the background of the urinary symptoms of a young, 31-year-old male patient pelvic MRI revealed a multilocular cystic tumor measuring 7.6 cm in diameter on the right side of the pelvis. Given his symptoms and the possibility of malignancy, a transperitoneal laparoscopic resection was performed. Histological examination confirmed the diagnosis of prostatic cystadenoma, and an incidental finding of Gleason-grade 3 + 3 adenocarcinoma was also noted in a small focus. Postoperatively, the patient became completely asymptomatic, with neither urinary symptoms nor erectile/ejaculatory dysfunction. A follow-up MRI performed 3 months later showed no recurrence, and PSA levels showed significant regression. The patient continues to be monitored closely. The prostatic cystadenoma is an exceedingly rare benign tumor, with fewer than 50 cases reported to date. Preoperative diagnosis is challenging due to the nonspecific nature of its compressive urogenital and gastrointestinal symptoms. Basic investigations, such as physical examination, ultrasound and PSA testing, are often uninformative. More detailed diagnostic information can be obtained through higher-order imaging studies (CT, pelvic MRI) or cytological/histological sampling via fine needle or core biopsy. The treatment of prostatic cystadenoma is primarily surgical, involving resection or excision through various approaches (transurethral, laparoscopic, robotic, or open surgery). Complete removal of the tumor is crucial, as incomplete resection is associated with high rate of recurrence. Although prostatic cystadenomas typically exhibit indolent behavior, a case of concurrent high-grade prostatic intraepithelial neoplasia and a further description of conventional adenocarcinoma have been already published. This case is noteworthy as it represents the second documented co-occurrence of prostatic cystadenoma and adenocarcinoma (collision tumor), according to the current literature. Orv Hetil. 2024; 165(52): 2065–2071.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[1例年轻男性多房性前列腺囊腺瘤和偶发低危性腺癌的合并发生]。
在泌尿系统症状的背景下,31岁的年轻男性患者骨盆MRI显示骨盆右侧有一个直径7.6 cm的多室囊性肿瘤。鉴于他的症状和恶性肿瘤的可能性,我们进行了经腹腔腹腔镜切除术。组织学检查证实了前列腺囊腺瘤的诊断,并在小病灶中偶然发现gleason级3 + 3腺癌。术后,患者完全无症状,无泌尿系统症状,也无勃起/射精功能障碍。3个月后复查MRI未见复发,PSA水平明显下降。患者将继续受到密切监测。前列腺囊腺瘤是一种极为罕见的良性肿瘤,迄今为止报道的病例不足50例。由于其压迫性泌尿生殖器和胃肠道症状的非特异性,术前诊断具有挑战性。基本的调查,如身体检查、超声和PSA检测,往往是缺乏信息的。更详细的诊断信息可以通过高阶成像研究(CT,骨盆MRI)或通过细针或核心活检进行细胞学/组织学采样获得。前列腺囊腺瘤的治疗主要是外科手术,包括通过各种途径(经尿道、腹腔镜、机器人或开放手术)切除或切除。完全切除肿瘤是至关重要的,因为不完全切除与高复发率有关。尽管前列腺囊腺瘤通常表现为惰性行为,但已经发表了一例并发的高级别前列腺上皮内瘤变和对常规腺癌的进一步描述。该病例值得注意,因为根据目前的文献,它是第二例记录的前列腺囊腺瘤和腺癌(碰撞瘤)共存的病例。奥夫·海泰尔。2024;165(52): 2065 - 2071。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Orvosi hetilap
Orvosi hetilap MEDICINE, GENERAL & INTERNAL-
CiteScore
1.20
自引率
50.00%
发文量
274
期刊介绍: The journal publishes original and review papers in the fields of experimental and clinical medicine. It covers epidemiology, diagnostics, therapy and the prevention of human diseases as well as papers of medical history. Orvosi Hetilap is the oldest, still in-print, Hungarian publication and also the one-and-only weekly published scientific journal in Hungary. The strategy of the journal is based on the Curatorium of the Lajos Markusovszky Foundation and on the National and International Editorial Board. The 150 year-old journal is part of the Hungarian Cultural Heritage.
期刊最新文献
[The symptoms of burnout and possible interpretations among the healthcare workers of the Emergency Department in Szentes]. [György Heisler, who first promoted variolation in Hungarian language in 1791]. [Analysis of pharmaceutical utilization data of strong opioids prescribed for baseline and breakthrough cancer pain in Hungary]. [Psychotropic drug-induced obesity in older adults: complications, preventive and therapeutic interventions]. [Bullous pemphigoid and primary biliary cholangitis, a rare association with therapeutic challenge].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1